Founded in 2003, AMELAF represents 45 Mexican companies that operate 79 pharmaceutical plants throughout Mexico.

AMELAF works to influence public policies to the benefit of Mexico and its pharmaceutical industry.

The Association promotes a pharmaceutical industry that is responsible and trustworthy: Mexican laboratories that produce high-quality generic medicines that are safe, effective, and affordable for Mexico's population.